Principal Investigators

    Chakravarty, Megha MPruessner, Jens C


    Douglas Hospital Research Centre (Verdun, Québec)

    Contact information of lead PI



    Title of project or programme

    Imaging-genetics biomarkers for disease risk in Alzheimer's Disease.

    Source of funding information


    Total sum awarded (Euro)

    € 292,141

    Start date of award


    Total duration of award in years



    Research Abstract

    Alzheimer’s disease represents a mounting challenge to our nation’s healthcare system. Individuals that suffer from Alzheimer’s disease typically suffer from an illness known as mild cognitive impairment (MCI) first. Our preliminary data for this application shows that those individuals that convert from MCI to Alzheimer’s demonstrate patterns of brain degeneration that are detectable at least one year before they convert. We then analyzed the neuroanatomy of individuals that were stable at MCI over the course of one year found that known genes that augment risk for disease may also predict this pattern of brain degeneration. The goal of this proposal is to combine genetic and magnetic resonance imaging data to provide a more accurate index of this conversion. A successful application will have a broad impact on health care and may provide potential targets for drug development.

    Further information available at:

Types: Investments < €500k
Member States: Canada
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF